Plus Therapeutics Inc. (PSTV) PT Raised to $5.25 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts PSTV Hot Sheet
Price: $1.63 -3.55%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo raised the price target on Plus Therapeutics Inc. (NASDAQ: PSTV) to $5.25 (from $5.00) while maintaining a Buy rating.
You May Also Be Interested In
- QuantumScape (QS) PT Lowered to $6 at Truist Securities
- Canfor Pulp Products (CFX:CN) (CFPUF) PT Raised to Cdn$2.75 at Raymond James
- Comerica (CMA) PT Raised to $54 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
